These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6659661)

  • 1. [Gastrointestinal diseases. Therapy with Iberogast].
    Bremer W; Fischer F; Nicolay K
    ZFA (Stuttgart); 1983 Oct; 59(30):1706-9. PubMed ID: 6659661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of drug-induced gastrointestinal disorders. Double-blind study of the effectiveness of Iberogast compared to placebo].
    Mac Lean N; Hübner-Steiner U
    Fortschr Med; 1987 Apr; 105(12):239-42. PubMed ID: 3297957
    [No Abstract]   [Full Text] [Related]  

  • 3. Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders : A noninterventional study with Iberogast®.
    Raedsch R; Vinson B; Ottillinger B; Holtmann G
    Wien Med Wochenschr; 2018 Mar; 168(3-4):89-98. PubMed ID: 28744774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience with a new benzodiazepines derivative: the RO-5-3350 in fundamental functional diseases of the gastrointestinal system].
    Herrerias Gutierrez JM
    Rev Esp Enferm Apar Dig; 1974 May; 43(3):343-8. PubMed ID: 4839158
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men.
    Pilichiewicz AN; Horowitz M; Russo A; Maddox AF; Jones KL; Schemann M; Holtmann G; Feinle-Bisset C
    Am J Gastroenterol; 2007 Jun; 102(6):1276-83. PubMed ID: 17378904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome)--from phytomedicine to "evidence based phytotherapy." A systematic review].
    Saller R; Pfister-Hotz G; Iten F; Melzer J; Reichling J
    Forsch Komplementarmed Klass Naturheilkd; 2002 Dec; 9 Suppl 1():1-20. PubMed ID: 12618546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of functional gastroduodenal evacuation disorders with metoclopramide (Paspertin)].
    Schütz E
    Munch Med Wochenschr; 1967 Jun; 109(22):1227-31. PubMed ID: 5631741
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of prolonged gastrointestinal paralysis].
    Kronberger L
    Dtsch Med J; 1969 Jul; 20(14):459-62. PubMed ID: 5808047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term therapy of gastrointestinal diseases with gastronerton].
    Tolva D; Testaguzza F
    Med Welt; 1980 Feb; 31(6):230-3. PubMed ID: 7366403
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-instrumental study of the therapeutic action of a new parasymaptholytic].
    Barbara L; Corinaldesi R; Macaluso G; Luchetta L; Ricci P; Casadio R; Miglioli M
    Clin Ter; 1976 Dec; 79(6):523-47. PubMed ID: 12909
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of digestive insufficiencies using enzyme harongan].
    Vorberg G
    Munch Med Wochenschr; 1972 Oct; 114(41):1773-4. PubMed ID: 4678588
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrogastroenterographic control of the digestive effects of N-butyl hyoscine bromide].
    Martin A; Thillier JL; Moline J; Levet E; Quentin JC
    Therapie; 1972; 27(3):457-63. PubMed ID: 4655210
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatments with the phytopharmaceuticals bilicura and spasmobilicura in disorders of the liver-bile-digestive system].
    Gracza L; Gracza E
    Fortschr Med; 1977 Dec; 95(47-48):2829-31. PubMed ID: 590909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fitovit and other medicinal species in the treatment of dysbacteriosis].
    Kosov VA; Ermolin SN; Popov IuV
    Voen Med Zh; 1996 Sep; 317(9):53-6. PubMed ID: 8992752
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacology of drugs acting on gastrointestinal motility].
    Van Nueten JM; Schuurkes JA
    Z Gastroenterol; 1988 Nov; 26 Suppl 4():4-8. PubMed ID: 3070983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of prostaglandins on the motor function of the large intestine].
    Shirokova KI; German SV; Kochina EN
    Klin Med (Mosk); 1980 Sep; 58(9):72-5. PubMed ID: 7412198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diseases of gastrointestinal motility. Treatment with motility-modifying substances].
    Storr M; Allescher HD
    Med Monatsschr Pharm; 2003 Aug; 26(8):260-9. PubMed ID: 12953379
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endoscopic observations in patients with gastroduodenopathies during treatment with a drug association with antivagal and tranquilizing action].
    Mirelli E; Fichera G
    Minerva Med; 1967 Sep; 58(70):2967-81. PubMed ID: 4383245
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled clinical study of a new preparation for the treatment of digestive disorders].
    Mereto GC
    Minerva Gastroenterol; 1975; 21(1):31-4. PubMed ID: 1207938
    [No Abstract]   [Full Text] [Related]  

  • 20. [Motility-modifying drugs].
    Storr M; Allescher HD
    Internist (Berl); 2000 Dec; 41(12):1318-24, 1326-30. PubMed ID: 11189067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.